These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8475901)

  • 41. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
    Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
    J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunophenotyping of hematologic neoplasms in paraffin-embedded tissue sections.
    Davey FR; Elghetany MT; Kurec AS
    Am J Clin Pathol; 1990 Apr; 93(4 Suppl 1):S17-26. PubMed ID: 2180277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunophenotyping of leukemic stem cells and chromosome karyotype characteristics in Uyghur leukemia pediatric patients].
    Hailiqiguli N; Yan M
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):501-4. PubMed ID: 24257300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flow cytometric detection of residual disease in acute leukemia by assaying blasts co-expressing myeloid and lymphatic antigens.
    Syrjälä M; Anttila VJ; Ruutu T; Jansson SE
    Leukemia; 1994 Sep; 8(9):1564-70. PubMed ID: 7522295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow Cytometry for Non-Hodgkin and Hodgkin Lymphomas.
    Gajzer D; Glynn E; Wu D; Fromm JR
    Methods Mol Biol; 2025; 2865():31-59. PubMed ID: 39424719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.
    Bendall LJ; Kortlepel K; Bradstock KF; Gottlieb DJ
    Leukemia; 1995 Jun; 9(6):999-1005. PubMed ID: 7596192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Morphological, immunological and cytogenetic diagnosis in acute leukemias].
    Ratei R; Sperling C; Ludwig WD
    Ther Umsch; 1996 Feb; 53(2):88-96. PubMed ID: 8629269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunophenotyping in the diagnosis of non-Hodgkin lymphomas: a literature review].
    Rauh S; Duhem C; Mahassen P; Ries F; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1996; 133(2):27-33. PubMed ID: 9064220
    [No Abstract]   [Full Text] [Related]  

  • 50. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
    Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
    Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic significance of CD40, CD40L, and CD26 expression in Hodgkin's disease and other lymphomas.
    Carbone A; Gloghini A
    Am J Clin Pathol; 1996 Apr; 105(4):522-3. PubMed ID: 8604696
    [No Abstract]   [Full Text] [Related]  

  • 52. Generation of lymphokine-activated killer cells with veto and natural suppressor activity from patients with leukemias and lymphomas.
    Cheruku R; Uberti J; Martilotti F; Kaplan J
    Transplantation; 1993 Oct; 56(4):1037-40. PubMed ID: 8212188
    [No Abstract]   [Full Text] [Related]  

  • 53. Clonal development of the acute leukemias.
    Fialkow PJ; Raskind WR; Singer JW; Dow LW; Najfeld V; Veith R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():76-8. PubMed ID: 2653523
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical significance of standard CD assessment in acute leukemia.
    Tupitsyn NN; Babusíková O; Baryshnikov AYu ; Ujházy P; Kadagidze ZG; Mahonova LA; Peterson IS; Protasova AK; Drozdova TS; Artemjev AK
    Neoplasma; 1990; 37(4):431-8. PubMed ID: 2146517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hybrid leukemia among acute childhood leukemias].
    Koehler M; Bubała H
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):347-9. PubMed ID: 1437751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A T-lineage neoplasm-Which one?
    Bain BJ; Fawcett N
    Am J Hematol; 2009 Oct; 84(10):678. PubMed ID: 19373891
    [No Abstract]   [Full Text] [Related]  

  • 57. Gating strategy for immunophenotyping of leukemia and lymphoma.
    Sun T; Sangaline R; Ryder J; Gibbens K; Rollo C; Stewart S; Rajagopalan C
    Am J Clin Pathol; 1997 Aug; 108(2):152-7. PubMed ID: 9260755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid detection of neoplastic cells in serous cavity effusions in children with flow cytometry immunophenotyping.
    Shen H; Tang Y; Xu X; Wang L; Wang Q; Xu W; Song H; Zhao Z; Wang J
    Leuk Lymphoma; 2012 Aug; 53(8):1509-14. PubMed ID: 22288605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD163: a specific immunohistochemical marker for acute myeloid leukemia with monocytic differentiation.
    Garcia C; Gardner D; Reichard KK
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):417-21. PubMed ID: 18542032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
    Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
    Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.